{"raw_mentions": "Figure 3 shows the results of a plaque inhibition assay using Vero cells of the SARS-CoV-2 plaque inhibition assay, in which IFN \u03b1 2a (a commercially available subtype) was compared to IFN \u03b1 14 and shows an IC 50-indicating that \u03b1 -14 is 20X more potent against Covid19 virus than \u03b1 -2 a."}
{"final_json": [{"molecule_name": "IFN \u03b1 14", "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "IFN \u03b1 2a", "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}]}
